USD 4.80 billion
Allergy Diagnostics Market Size, Share, Growth Analysis, By Product(Consumables, Instruments (Immunoassay Analyzers, ELISA Analyzers, Luminometers), By Allergens(Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens), By Test Type(Vivo Tests (Skin Prick Tests, Patch Tests, Other In Vivo Tests), In Vitro Tests), By End User(Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users), By Region - Industry Forecast 2024-2031
Report ID:
SQSG35I2040 |
Region:
Global |
Published Date: September, 2024
Pages:
165
|Tables:
123
|Figures:
73
Allergy Diagnostics Market Insights
Allergy Diagnostics Market size was valued at around USD 4.3 billion in 2022 and is expected to rise from USD 4.8 billion in 2023 to reach a value of USD 11.1 billion by 2031, at a CAGR of 11% over the forecast period (2024–2031).
The allergy diagnostics market has been witnessing notable growth in the recent past, impacted by the growing prevalence of allergies, improvements in diagnostic technologies, and rising awareness of allergy testing. There has been a notable rise in commonly seen allergic conditions like hay fever, asthma, and multiple food allergies along with numerous environmental factors and lifestyle changes. All these majorly contribute to the expansion of the allergy diagnostics market. Moreover, modernizations in diagnostic technologies and tools, including skin prick tests, vitro testing, and molecular diagnostics improve efficiency and accuracy.
Nevertheless, the global allergy diagnostics market is restrained by different regulatory hurdles and significantly priced diagnostic technologies. Stringent regulations associated with diagnostic tests may notably slow down the market entry of novel products and technologies, which may hamper market growth. Also, the high price of advanced diagnostic technologies may be a challenge for a few patients as well as for most healthcare systems. In addition, lack of standardization may hinder market growth. Due to absence of standardized testing procedure, the test may offer variable results, thus reducing overall reliability of allergy diagnostics. Yet, the market is projected to witness considerable growth owing to opportunities like emergence of innovative diagnostic procedures, integration of ML and AI, and heavy investments in healthcare infrastructure and growing awareness of allergies and benefits of diagnostics.
US Allergy Diagnostics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024–2031
Global Market Size
Largest Segment
Inhaled Allergens
Fastest Growth
Inhaled Allergens
Growth Rate
11.10% CAGR
Global Allergy Diagnostics Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Allergy Diagnostics Market Segmental Analysis
Global Allergy Diagnostics Market is segmented by product, allergen, test type, end user, and region. Based on Product, the market is segmented into Consumables, Instruments (Immunoassay Analyzers, ELISA Analyzers, Luminometers, Other Instruments), Services. Based on Allergens, the market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens. Based on Test type, the market is segmented into Vivo Tests (Skin Prick Tests, Patch Tests, Other In Vivo Tests), In Vitro Tests. Based on End User, the market is segmented into Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Allergy Diagnostics Market Analysis by Product
Based on product, the allergy diagnostics market is categorized into consumables, instruments, and services. The consumables segment held a notable share of the market in the previous years and is expected to lead over the forecast period as well owing to high volume testing, cost-effectiveness, and speedy technological improvements. Allergy diagnostics mostly need continuous monitoring and repetitive testing, which propels the need for consumables products, including reagents, test kits, and several disposable materials. Consumables are comparatively affordable than the instruments, thus increasing their preference for a large number of patients and medical professionals. Moreover, innovations in testing techniques increase reliability and efficacy of consumables, resulting in frequent use.
On the other hand, the instruments segment is projected to grow considerably over the forecast period owing to improved technology, long-term value, incorporation with automation, and exhaustive testing competencies. Instruments integrate superior technology that improve speed, accuracy and reliability of allergy testing. This increases their significance in advanced diagnostic processes. Despite being costly, instruments offer long-term value by allowing a broader range of tests and precision in laboratories. Several instruments are carefully designed to be incorporated in automation systems for enhanced efficacy and minimized human error in testing procedures. They mostly enable multiplex testing, allowing concurrent study of numerous allergens, which is actively demand in clinics.
Allergy Diagnostics Market Analysis by End User
Based on end user, the market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end users. The diagnostic laboratories segment held a notable market share in the previous years and is expected to continue dominance over the forecast period as well owing to specialization offered in these settings, high testing volume, and access to modernized equipment. Diagnostic laboratories offer access to improved technologies and proficient and expert personnel, enabling comprehensive and accurate testing of allergies. These settings manage huge quantities of tests regularly, promoting economies of scale, which allows them to improve their service offerings and operational efficiency.
On the other hand, the hospital-based laboratories segment will hold a remarkable market share in the coming years owing to the integrated patient care, growing patient volume, access to modernized resources, and alliance with experts. Hospital-based labs offer quick access to testing as a unit of exhaustive patient care. This streamlines treatment and timely diagnosis. Hospitals manage large patient volumes that increase the need for quality diagnostic tests like allergy examinations. These labs also have better access to improved technologies and an expert workforce, confirming efficient and accurate testing. Also, hospital labs usually work with allergists and other experts, allowing simplified processes for allergy management and diagnosis.
Global Allergy Diagnostics Market Size By Product
To get detailed analysis on other segments, Request For Free Sample Report
Allergy Diagnostics Market Regional Insights
Region-wise, North America dominated the market in the previous years and is expected to lead over the forecast period owing to rising incidences of allergies, improved healthcare infrastructure, and education and strong awareness. The region reports a higher number of allergic conditions as compared to other regions. These comprise various food allergies, allergic rhinitis, asthma, and more, which demand on reliable diagnostic facilities a large scale. Also, North America holds a well-established healthcare infrastructure with easy access to superior diagnostic techniques and an expert workforce. This streamlines accuracy and time testing. Also, the public awareness regarding allergies is higher than other regions, resulting in proactive medical industry seeking high demand for testing. The key players profiled in the region include Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, Roche Diagnostics, ALK-Abelló, and more.
Asia-Pacific is the fastest-growing region in the global allergy diagnostics market due to the rising number of allergic conditions, progressing healthcare infrastructure, education and growing awareness, and investments in technology. The number of allergic conditions is increasing in the region due to growing urbanization, environmental factors, and changing lifestyles. This ultimately creates the demand for efficient allergy testing. Most nations are actively investing in healthcare developments and increasing access to numerous diagnostic services, improving their availability. Also, growing awareness and education among patients and their health is fueling inclination towards treatment and diagnostics. Emphasis on advanced diagnostics techniques like molecular diagnostics increases efficiency and accuracy, thus impacting the market growth in the region.
Global Allergy Diagnostics Market Size By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Allergy Diagnostics Market Dynamics
Allergy Diagnostics market Driver
Rising Trend of Personalized Medicine
- The inclination towards personalized medicine is notably impacting allergy diagnostics. There is an increase demand for allergy tests that offer deep vision into personal sensitivities, enabling for more customized and personalized treatment decisions. Current research in detecting certain biomarkers associated with allergies improves the ability to create tailored treatment tactics, thus impacting the market growth.
Impact of Environmental Factors
- Increasing pollution and climate change along with lifestyle changes significantly impacts the rise of allergies, thus driving the market growth. Increased pollution and changing climate are notably contributing to increased rates of allergies, especially respiratory-associated allergies. Dietary changes, urban living, and exposure to novel allergens like synthetic materials may increase the rate of allergies. This impacts the demand for accurate diagnostic solutions.
Restraints
Strong Competition from Alternate Techniques
- Rise of home test kits and DIY approaches is negatively impacting the market growth. The progress of home-based allergy testing kits offers more convenience to patients. But they are comparatively less accurate than the lab-based diagnostics, which possibly shifts patient’s interest from professional testing. This may notably affect demand for professional facilities and market growth. Patients may also adopt DIY methods and home remedies, which may again hinder the market growth.
Technical Limitations to Restrain Market Growth
- Specificity and sensitivity issues and complexity of growing number of reactions may be a challenge, thus affecting the market growth. While most improvements in technologies have enhanced accuracy of diagnosis, a few tests are still striving with specificity and sensitivity. This results in false negatives or positives and affects a patient’s trust. Allergies may also be multi-layered and hence, one test may not be effective to capture all sensitivities, increasing the complexity.
Request Free Customization of this report to help us to meet your business objectives.
Allergy Diagnostics Market Competitive Landscape
The competitive landscape of the global allergy diagnostics market is differentiated by the amalgamation of emerging companies and well-established players with ongoing strategic partnerships and innovations, reshaping the market. Prominent players like Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, and Roche are focusing on in vitro diagnostics, comprehensive allergen testing competencies, and improved diagnostic tests and platforms for the detection of allergies. Furthermore, small enterprises and progressing companies are emphasizing niche products or modernized testing techniques like digital health solutions and molecular diagnostics. To boost rankings, established companies are heavily investing in R&D, engaging in collaborations, and increasing their geographic presence.
Allergy Diagnostics market Top Player’s Company Profiles
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Canon, Inc. (Minaris Medical America, Inc.)
- Siemens Healthineers AG
- Eurofins Scientific
- Revvity, Inc. (Euroimmun Medizinische Labor diagnostika AG)
- BioMérieux SA
- Stallergenes Greer Ltd.
- Romer Labs Division Holding GmbH
- HollisterStier Allergy
- Omega Diagnostics Group PLC
- HOB Biotech Group Corp., Ltd.
- Hycor Biomedical
- Lincoln Diagnostics, Inc.
- R-Biopharm AG
- Astra Biotech GmbH
- Erba Group
- AESKU.GROUP GmbH
- ACON Laboratories, Inc.
- Alcit India Pvt. Ltd.
- Biopanda Reagents Ltd.
- Bioside S.R.L.
- Creative Diagnostic Medicare Pvt. Ltd.
- DST Diagnostische Systeme & Technologien GmbH
- Dr. Fooke Laboratorien GmbH
Allergy Diagnostics market Recent Development
- In September 2023, Stallergenes Greer announced an agreement with Nestlé to connect the allergy oral immunotherapy treatment Palforzia®. With this agreement, Nestlé will get momentous royalties and payments from Stallergenes Greer. There will be an ordinary period to confirm continuity of business and offer unbroken access to patients for treatments.
- In June 2023, EUROIMMUN, a subsidiary of Revvity Incorporation launched a novel automated system for (IIFT) indirect immunofluorescence test, named UNIQO 160 (CE-IVDR) for diagnosis of autoimmune diseases. It is an all-inclusive solution that automates the whole IIFT procedure, starting from sampling to image analysis and offers reliable and fast results.
- In March 2023, Thermo Fisher Scientific declared that it increased the availability of ImmunoCAPTM Specific IgE tests to a greater number of patients in the United States. These ImmunoCAPTM tests are currently made available to individuals at Kroger Health’s The Little Clinic LLC locations via blood sample taken on site.
Allergy Diagnostics Key Market Trends
- Mounting Use of Molecular Diagnostics: Molecular diagnostic techniques like allergen component testing and next-generation sequencing are gaining prominence. These techniques enable more accurate detection of certain allergens at molecular stage. This trend improves precision of diagnostics, allowing better customized treatment plans depending on patient sensitivities. This ultimately results in better patient results. The commonly used molecular diagnostic methods include ELISA, PCR, and NHS.
- Incorporation of Digital Health Solutions: The growth of mobile health solutions and telemedicine is considerably transforming the delivery of allergy diagnostics. Solutions that enable monitoring in real-time and remote testing are also gaining prominence. This integration increases access to allergy testing for patients and streamline easy sharing of data with medical professionals. This improves patient engagement in better management of their conditions.
Allergy Diagnostics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the allergy diagnostics market is considerably progressing due to growing incidences of allergies including rhinitis, asthma, and numerous food allergies. The market is also fueled by advancements in technologies like improved molecular diagnostics and high-throughput screening techniques and major investments in healthcare infrastructure, mainly in the developing regions. However, the market is hampered by significantly priced advanced diagnostics technologies like multiplex testing and advanced molecular diagnostics. North America is anticipated to lead the market owing to the strong regulatory framework that guarantees the safety and quality of diagnostic tests, major investments in research and development, and increased education and awareness of allergies and testing techniques. Nonetheless, a few opportunities for the growth of the allergy diagnostics market include the emergence of innovative diagnostic methods, expansion in the progressing markets like Latin America, Asia-Pacific, and Africa, and the rising trend of personalized medicine.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 4.3 billion |
| Market size value in 2031 | USD 11.1 billion |
| Growth Rate | 11% |
| Base year | 2023 |
| Forecast period | 2024–2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Allergy Diagnostics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Allergy Diagnostics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Allergy Diagnostics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Allergy Diagnostics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Allergy Diagnostics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Allergy Diagnostics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
